BioLamina (private company)
See something wrong or missing? Let us know
Offices:Sundbyberg
Industry:BiotechHealth servicesManufacturing
Business model:B2B
BioLamina is a biotech startup from Sweden developing proteins and cell culture matrices - recombinant human laminins, which are key proteins enabling researchers and biopharma to grow, manipulate, and engineer both stem cells and certain primary cells.
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 18.55M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to BioLamina
Name | Criteria | |
---|---|---|
![]() |
CatalYm
63%
|
|
![]() |
InnovaFeed SAS
63%
|
|
![]() |
Memo Therapeutics
63%
|
|
![]() |
Peptomyc
63%
|
|
![]() |
Peptone
63%
|
|
![]() |
Salvia BioElectronics
63%
|
|
![]() |
Sarcura
63%
|
|
![]() |
Synendos Therapeutics
63%
|
|
![]() |
Bactolife
63%
|
|
![]() |
Cytoki Pharma
63%
|
|